Evaluating Outcomes and Risk Factors of Different Treatments for Neuro-co-cardiological and Post-Cardiac Surgery Cerebrovascular Diseases

What this Trial Is About

Researchers are evaluating the clinical outcomes of different treatment strategies for neuro-co-cardiological diseases and cerebrovascular diseases following cardiac surgery. This observational study also aims to identify factors that influence negative outcomes from these treatments. The trial is sponsored by Beijing Anzhen Hospital and focuses on patients aged 18 years and older with these specific conditions. Participants are grouped based on the treatment approach they receive, including simultaneous interventional, surgical, or hybrid surgical treatments staged interventional, surgical, or hybrid treatments conservative treatment alongside surgery or intervention and treatments specifically for cerebrovascular disease following cardiac surgery, either surgicalinterventional or conservative. These treatment strategies are observed without intervention from the study team. During the study, participants will be monitored using the Modified Rankin Scale Score at various time points including around 7 days, 90 days, and one year. The study also tracks perioperative complications and rates of cardiovascular and cerebrovascular events up to one year. Participants will undergo evaluations to assess both short-term and long-term complications related to their treatment. The total duration of involvement varies based on follow-up assessments up to 365 days.

Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases